SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/8E928F7F10A7D269DDCAF6AC645327A291A80503F965C6E84D4FE2D660D13CAF10C09DAA38EDC3EE4D2C758F6F607EE3>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/8E928F7F10A7D269DDCAF6AC645327A291A80503F965C6E84D4FE2D660D13CAF10C09DAA38EDC3EE4D2C758F6F607EE3
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/8E928F7F10A7D269DDCAF6AC645327A291A80503F965C6E84D4FE2D660D13CAF10C09DAA38EDC3EE4D2C758F6F607EE3
http://www.w3.org/2000/01/rdf-schema#comment
"Tissue pathway factor inhibitor (TFPI) activity is elevated in pregnant patients at 20 weeks gestation who subsequently develop preeclampsia."
xsd:string
http://purl.uniprot.org/uniprot/#_EE39BBD2E5CB6408585A438B2AC413EA1377027AA44C9881BE26C6EED4F60AE82B5659650557921CD191BE36BDEBD7B6
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/8E928F7F10A7D269DDCAF6AC645327A291A80503F965C6E84D4FE2D660D13CAF10C09DAA38EDC3EE4D2C758F6F607EE3
http://purl.uniprot.org/uniprot/P10646
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/8E928F7F10A7D269DDCAF6AC645327A291A80503F965C6E84D4FE2D660D13CAF10C09DAA38EDC3EE4D2C758F6F607EE3
http://purl.uniprot.org/uniprot/#_P10646-mappedCitation-19350127
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/8E928F7F10A7D269DDCAF6AC645327A291A80503F965C6E84D4FE2D660D13CAF10C09DAA38EDC3EE4D2C758F6F607EE3